Cures Acceleration Network: BIO Strongly Supports the CAN Program

Implementation of CAN will help NIH-funded researchers bridge the precarious gap between basic research and the eventual development of new cures and treatments for many of the diseases we face today.</p>

On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for $500 million for Cures Acceleration Network (CAN) Act, a new initiative at the National Industries of Health (NIH) that was authorized in the recently-enacted Patient Protections and Afforadable Care Act.

Read BIO’s letter to the Senate Appropriations Committee